The Dynamic Landscape of Novel Psychoactive Substance (NPS) Use in Ireland: Results from an Expert Consultation by van Hout, MC
1 
Abstract 
In Ireland, legislators encountered a new phenomenon in 2005 onwards with the advent of 
‘legal highs’ sold in headshops.  Use of ‘legal highs’ containing herbal and synthetic new 
psychoactive substances (NPS) was not confined to problematic drug users, and included 
social recreational users. Legislative controls were enacted in 2010, 2011 and 2015. This 
brief report presents descriptive findings from a consultation with national and regional 
experts on the NPS situation in 2016. Four themes emerged and centred on; ‘Definitions of 
NPS used within Professional Roles’; ‘Professional Experiences of NPS‘; ‘Types of NPS 
Users, Sourcing and Consequences of Use’; and ‘Service Response.’ Findings underscored 
the mental health and addiction related consequences of NPS use, with prevention, clinical 
and treatment services ill- equipped to deal with the particular characteristics of this form of 
drug abuse. Enhanced strategies, services and clinical responses are warranted to address the 
challenges encountered. 
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Introduction 
In Ireland, legislators encountered a new phenomenon in 2005 onwards with the advent of 
‘legal highs’ sold in headshops 1 (Kavanagh and Power, 2014). By May 2010, numbers of 
headshops had increased to 102, equating to one shop per 45,000 people (Smyth et al., 2015). 
A new wave of legitimate drug consumerism was observed and occurred at a time of poor 
street quality of conventional street drugs such as MDMA, amphetamine and cocaine (Van 
Hout, 2012). Headshop retailers complied with Irish law and marketed products as ‘legal’ 
and ‘not for human consumption’, despite products containing herbal and novel psychoactive 
substances (NPS) and labelled with drug associated nomenclature (Van Hout, 2012). Use of 
NPS was not confined to problematic drug users, and included social recreational users 
(McElrath and Van Hout, 2011; Van Hout and Brennan, 2011a; Van Hout and Bingham, 
2012). Decisions to try NPS were reportedly influenced by 24 hour availability and pricing, 
home delivery, advertising, perceived level of protection and distance from the illegal drug 
trade, and lack of confirmed urine analysis for those in the treatment system (Van Hout and 
Brennan, 2011a;b;c; Ryall and Butler, 2011, McElrath and Van Hout, 2011; Van Hout and 
Bingham, 2012). Users appeared to perceive products as safe, with little awareness around 
lack of regulation and risk relating to toxicity (Van Hout, 2012). Clinical concerns at the time 
centred on the rise in presentation of users with psychosis and suicidal ideation (Tully et 
al.,2011; O'Domhnail and Ni Chleirigh, 2011; El-Higaya et al., 2011; Uhoegbu et al., 2011). 
Political and social concern contributed to a series of national legislative controls in 2010 and 
more recently in 2015 (Ryall and Butler, 2011; Health Research Board, 2016). Pre-legislative 
studies indicated that Irish NPS users were not deterred by impending legislative controls, 
and reported stockpiling of products (particularly the synthetic cathinone, Mephedrone) and 
1 A head shop is a retail outlet which specialises in drug paraphernalia related to consumption of 
cannabis, other recreational drugs, and New Age herbs, as well as counterculture art, magazines, music, 
clothing and home decor. 
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accessing of online retailers (McElrath and Van Hout, 2011; Van Hout and Brennan, 
2011a;b). Small-scale post legislative studies reported on a ‘temporary displacement’ with 
users either ceasing use or switching back to the conventional street sourcing (Van Hout and 
Brennan, 2011a:b; McElrath and Van Hout, 2011). In later years, legislative controls were 
speculated to have incurred some positive results, with small scale studies reporting on 
reduction of cathinone derivatives in post-mortem blood samples and urine samples of 
methadone programme patients (Kavanagh and Power, 2014); and reduced prevalence of 
NPS use in high risk youth (Smyth et al., 2015); and treated heroin dependent adults 
(O’Byrne et al., 2013). The Eurobarometer (2014) has however reported on increases in 
young persons (15-24 years) use in Ireland.  In 2016, studies have reported on problematic 
use of synthetic cannabinoids (SCBs), 5f-AKB48 and 5F-PB-22 in border counties (Van 
Hout and Hearne, 2016), the rise in HIV incidence among people who inject drugs (PWID) 
using the synthetic cathinone, a-PVP (Giese et al., 2015) and media reporting on the spate of 
hospitalisations and fatalities due to consumption of other popular NPS; a-PVP, the stimulant 
4-methoxy analog of methamphetamine (PMMA), the synthetic psychedelics 2,5-dimethoxy-
4-bromophenethylamine  (2C-B), the psychedelic phenethylamines (2-CP, 2-Cl) and the 
derivative of 2-CI , 25I-NBOMe.  This brief report presents descriptive findings from a 
consultation with national and regional health professional experts on the NPS phenomenon 
in Ireland in 2016.  
 
Methods 
A qualitative study was conducted with 13 national and regional health professional experts 
across Ireland, and was undertaken as part of a large scale European funded study across five 
Member States. Participants were selected based on their expert status, (national and if not 
national, their regional status representing all regions in Ireland), and secondly their expertise in 
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the area of NPS, public health and addiction treatment. Participants represented national child 
protection and welfare, addiction psychiatry, harm reduction and addiction treatment; and 
regional drug education, community drug and alcohol services, primary care addiction 
treatment and rehabilitation, and clinical service management.  Ethical approval for the study 
was granted by Waterford Institute of Technology, Ireland in 2016. All participants were 
provided with information around the study’s aims, advised of confidentiality and anonymity, 
with participation indicating informed consent. A structured guide of questions was designed 
by the NPS Transnational Team (see www.npstransnational.org) based on the literature, and 
prior experiences in conducting research on NPS. The guide contained questions relating to the 
participant profile, their professional role as it related to NPS, their experience of types of NPS 
users, patterns of use and harms related to NPS use, their views on specific supply, demand and 
harm reduction approaches. Transcribed data consisting of 14,450 words was analysed using 
content analysis, through application of a structured, systematic coding scheme, in the form of 
open, axial and selective coding categories derived directly from the text (Hsieh and Shannon, 
2005). Four descriptive themes emerged from the data.  
 
Results 
Four females and nine males, with ages ranging from 30 to 59 years partook. Duration of 
professional experience ranged from 8 to 37 years (average 18 years), with four participants 
responsible for and operating within national health policy, clinical and addiction service 
levels, and the remainder responsible for regional remit of education, addiction treatment in 
primary care and community drug services.  
Definitions of NPS used within Professional Roles 
Definitions of NPS varied according to the participant’s professional role, and were generally 
confined within the regulatory domain and Irish legislative context. Many participants 
5 
 
labelled NPS within the context of products sold in headshops prior to 2010 and defined them 
as ‘head shop products’ and legal highs”. Many referred to NPS by type/brand name, for 
example ‘Mephedrone /Spice‘or according to their psychoactive effect.  
‘I define them as either stimulant or depressant, and identify them by the name 
that the service user calls them “Spice, Bath Salts, Incense” or if they have fitted 
a known validated description’. 
Participants described at length the dynamic nature of the designer NPS market and how 
surveillance and detection struggle to tackle continuously adapted products. Challenges in 
verification of NPS centred on chemical detection in drug seizures and urine analysis. 
Undetected compounds purchased on the Internet and entering Ireland via the postal system 
are labelled as ‘research chemical’; ‘animal or herbal products’.  
‘NPS are changing faster than the regulatory definitions, and indeed than the 
scientific community can confidently identify them.’  
 
Professional Experiences of NPS  
Contact with NPS users depended on level of case load contact, and ranged from referrals 
from schools, parents, social workers and Gardai (Irish police) through to daily case load with 
service users. Difficulties in estimating extent of NPS use in Ireland despite the rise in service 
concerns and increased referrals within the context of poly substance use, centred on lack of 
detection in urine screening (in treatment and prison settings), and prevalence surveillance.  
‘Difficult to quantify but services state that there is increasing use reflected in 
profile of clients presenting to services, as element of poly-drug use 
presentations.‘ 
‘As the NPS in vogue are being used on the street, we would often find that we 
are noticing a population effect’. 
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A lack of user awareness of harm and potential for overdose was described by many 
participants, particularly in the case of younger, more inexperienced users. Concerns centred 
on the rise in serious mental health admissions, and difficulties in treatment.  
‘The user cannot tell when the desired effect will begin, crescendo, or when the 
hangover will subside. This may be at odds with the seller’s description or the 
users perception, and may result in unintended consequences, such as doubling 
up the dose, or significant post use depression, similar to “Suicide Tuesday” 
from cocaine use. There are also significant short and long-term mental health 
effects from NPS, which have yet to be evaluated to the same degree as say 
cannabis and psychosis.’ 
 
Types of NPS users, Sourcing and Consequences of Use 
Participants recognised the wide range of NPS use across the Irish population. Specific 
groups of NPS users were identified, with some not engaging with health services,  
1) College students or young people at parties;  
2) ‘Chemsex’ men who have sex with men (MSM);  
3) Entrenched PWID seeking a cheap high not undetectable by routine screening;  
4) Co-morbid individuals with (often) primary mental illness and self medicating. 
‘There is a novice user who perceives less risk associated with NPS under the 
guise of disarming names, and street culture. These include party & festival goers 
and students. There is a regular pill user, who sees themselves as “street wise” 
and likes to think they know a lot about the different types of tablets and NPS 
being traded, and perceives they are in control of the NPS effects by balancing 
their use between “uppers and downers”. Then there is the chaotic drug user, 
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who is taking NPS as part of polydrug use, in an attempt to maintain a habit, or 
keep withdrawal symptoms at bay’. 
Poly substance use including a repertoire of NPS and conventional drugs was described as 
common, with popular NPS including SCBs, psychedelics, gamma-Hydroxybutyric acid 
(GHB) alternatives, psychedelic phenethylamines containing the 2-C substances, and 
cathinone stimulants such as a-PVP and Mephedrone. More recent trends included the opioid 
fentanyl analogue, flurofentanyl. Route of administration varied, with PWID and ‘Chemsex’ 
users often injecting, and recreational users in social night life ingesting, insufflating or 
smoking. General reasons for use of NPS centred on user curiosity, social influences, 
availability in the form of a ‘cheap high’, potency in comparison to conventional drugs, and 
for pleasure.  
‘For a ‘high’, curiosity, enhance sexual experience, inexpensive or in some cases 
free, ‘everyone else at the party was using’  
Participants distinguished between types of user in relation to sourcing methods, with PWID 
sourcing via existing street and peer networks, and social and ‘Chemsex’ users purchasing 
online and from friends. The internet was used by less chaotic users to source information on 
the Surface and Dark Net, with availability supported via mobile phone technology and social 
media.  
‘Students tend to get substances off friends. PWID tend to get from dealers. 
Chemsex may access drugs via websites and online shops with delivery to door’. 
Consequences of NPS use centred on short term impacts such paranoia, heightened 
aggression and sexual risk taking, insomnia and increased injecting risk behaviours in PWID. 
The stimulant nature of the NPS injected was observed to contribute to worsening outcomes 
relating to reduced harm reduction and compulsive re-dosing. Those engaging in injecting of 
NPS were reported to experience bacterial infections, cellulitis, phlebitis, deep vein 
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thrombosis (DVT), and weight loss, and more significantly than opiate injectors. Longer term 
impacts centred on unpleasant withdrawals, virus transmission (HIV and HCV), and 
deterioration of mental state.   
‘Short term agitation, anxiety, aggression. Some reports of increased sexual 
activity. Serious sleep deprivation for stimulant based substances. Serious impact 
on mental health. Reports of drug induced psychosis and long term mental health 
problems such as depression.’ 
An increase in severity and progression of dependence symptomatologies were described, 
and particularly negative in terms of mental health impact.  
‘More highly addictive and quicker to form habits.  Cessation has a higher 
negative effect on the mental health’. 
Particular concerns were voiced with regard to deterioration of mental health in the form of 
emotional instability, suicidal ideation and prevalence of inappropriate, violent and 
unpredictable behaviours, and the risks of acute psychosis and the onset of enduring mental 
health issues for those that are already vulnerable.  Psychotic episodes were described as 
difficult to treat and usually requiring long periods of hospitalisation.  
 
Service Response 
Participants underscored the need for national evidence based approach to clearly address 
emerging issues in NPS. Harm reduction efforts were recommended to include information 
on adverse acute and long term consequences of use, and supported by universal face to face, 
peer dissemination and internet campaigns targeting the different types of NPS users and 
those affected in their social network. 
‘The primary target audience for the current National Drug Strategy is aimed at 
opiate users which doesn’t meet the needs of the NPS population  The 
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development of a new strategy needs to reflect information in regards to 
prevention, early identification, early intervention and putting more resources 
into supporting protective factors.’ 
The need for enhanced targeted treatment and rehabilitation, and dual diagnosis service 
responses to address the poly substance using trends and particular consequences of NPS use 
appeared warranted. 
‘NPS are not recognised within treatment and rehabilitation pillars of National 
Drug Strategy, or prevention in relation to being able to deal with people who 
present with these issues.  It has no clear dual diagnosis strategic objectives or 
actions.  Mental health and psychosis are extreme in cases of NPS use and there 
are very limited dual diagnosis services.’ 
Clinical services were deemed ill-equipped to deal with the repercussions of NPS use and 
dependence, with participants highlighting the need for clinical guidance, enhanced 
collaboration between addiction and mental health services, and additional staff training and 
resources. 
‘Currently there is a scarcity of inpatient treatment facilities trained effectively to 
cope with NPS. Staff within services do not understand a lot of these drugs and 
their implications so adequate training is required.’ 
 
Discussion  
Increasing trends in the diversification, trafficking and use of NPS continue to present a 
global public health challenge (European Monitoring Centre for Drugs and Drug Abuse, 
EMCDDA, 2016).  Surveillance struggles to keep up with the ever increasing range of NPS 
with undocumented toxicological and psycho-activity risks (EMCDDA, 2015; Caudevilla, 
2013: 2016).  The Internet is driving change in contemporary global drug markets, and 
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particularly that of NPS (EMCDDA, 2016; Lavorgna, 2014; 2016; van Amsterdam et al., 
2016). The study illustrated a descriptive ‘snapshot’ of expert perspectives on the current 
situation in Ireland. Legislative challenges were viewed to centre on the detection in chemical 
analysis of NPS entering Ireland via the postal system, and also in the urine screening of 
users in prison and treatment settings.  Irish academics have highlighted the need for 
legislation to support collaborative intelligence gathering activities (Kavanagh and Power, 
2014).  For the most part legal status, legislative controls and regulation according to these 
experts had succeeded in closing headshop routes to supply, but with street and online 
availability contributing to continued and undeterred use of NPS among diverse populations 
of NPS users. The Global Drug Survey (2016) has reported that almost 10% of Irish users 
buy drugs on the internet, of which a third are NPS.  Social media is also playing a major role 
in the marketing and sale of NPS (Orsolini et al., 2015), and in the supporting of “Chemsex” 
participation (Lewnard and Berrang-Ford, 2014; Gilbart et al., 2014).   
 
Trends in poly substance use of popular NPS included synthetic cannabinoids, stimulant and 
psychedelic drugs. Motives for use are similiar to that reported elsewhere (Van Hout, 2014; 
Van Hout & Hearne, 2015; Soussan & Kjellgren, 2016; GDS, 2016). Despite legislation 
viewed as cross cutting between law enforcement and health (Ryall and Butler, 2011); service 
responses and preventative measures have not kept up with the increase in poly drug referrals 
which involve NPS, and the diverse range of NPS used in Ireland. Experts underscored 
concerns around service provision and clinical responses to the serious mental and physical 
health consequences of NPS, most often within poly drug repertoires, and compounded when 
injected. For those engaged in high risk behaviour such as ‘Chemsex’ and/or injecting drug 
use, risks of blood borne virus transmission are a significant concern (Giese et al., 2015; 
European Chemsex Forum, 2016).  An investment in staff training and resources, within an 
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evidence based approach is required in order to address the challenges relating to NPS use, 
and particularly now in the formulation of the next National Drug Strategy to support 
multidisciplinary efforts in prevention and treatment cognisant of the dual diagnosis 
complications.  
 
Conclusion 
The study whilst small scale is unique in terms of providing the national and regional snapshot 
of expert perspectives around NPS use in the Republic. Whilst legislation has reduced shop 
sales of NPS, online retail and influx of psychoactive substances into the Republic via the 
postal system remains an issue. Best practices from elsewhere are warranted to inform the next 
National Drug Strategy, and support prevention, harm reduction and clinical responses.   
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